Centro de Estudios Clínicos de Querétaro (CECLIQ)
Queretaro, Mexico
Doctor in Santiago de Querétaro
Torre II, Médica TEC100, Privada Ignacio Zaragoza 16, Interior H, Sótano 1, Centro, 76000 Santiago de Querétaro, Qro.
About Centro de Estudios Clínicos de Querétaro (CECLIQ)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Hoffmann-La Roche
2
Boehringer Ingelheim
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Centro de Estudios Clínicos de Querétaro (CECLIQ)
During the past decade, Centro de Estudios Clínicos de Querétaro (CECLIQ) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
2013-11-04
2018-10-08
Completed
979
Effects of Oral Sildenafil on Mortality in Adults With PAH
2014-09-22
2021-02-26
Terminated
385
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
2020-11-13
2023-01-25
Completed
390
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
2021-04-20
2024-07-30
Recruiting
700
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]
2022-10-20
2024-10-18
Active, not recruiting
254
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro de Estudios Clínicos de Querétaro (CECLIQ)
According to Clinical.Site data, the most researched conditions in "Centro de Estudios Clínicos de Querétaro (CECLIQ)" are
"Obesity" (2 trials), "Borderline Personality Disorder" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Lipoprotein Disorder" (1 trials). Many other conditions were trialed in "Centro de Estudios Clínicos de Querétaro (CECLIQ)" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Estudios Clínicos de Querétaro (CECLIQ)
Most popular intervention types in "Centro de Estudios Clínicos de Querétaro (CECLIQ)" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (3 trials), "Cyclophosphamide" (2 trials), "BI 1358894" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Estudios Clínicos de Querétaro (CECLIQ)
The vast majority of trials in "Centro de Estudios Clínicos de Querétaro (CECLIQ)" are
8 trials for "All" genders.
Clinical Trials Status at Centro de Estudios Clínicos de Querétaro (CECLIQ)
Currently, there are NaN active trials in "Centro de Estudios Clínicos de Querétaro (CECLIQ)".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centro de Estudios Clínicos de Querétaro (CECLIQ),
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Estudios Clínicos de Querétaro (CECLIQ), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".